Daily Dose - Aug 18th, 2025
Daily Dose |
View online
August 18, 2025
Q&A: WuXi AppTec’s key investment focus is on expanding capabilities for new modalities
Co-CEO Minzhang Chen says the increasing size and complexity of drug molecules require greater knowledge and a sophisticated approach.
Read More
WuXi Biologics Ireland site gets EMA approval for commercial biologics manufacturing
The Dundalk facility includes 6,000 liters of perfusion capacity and 48,000 liters of fed-batch capacity, making it a key hub in the Chinese CRDMO’s global network.
Read More
Oxford Biomedica expands U.S. capacity to meet viral vector demand
The $78 million investment will support large-scale GMP production, fill-finish, and advanced automation.
Read More